As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Pacira BioSciences Inc. The largest reported stake is Vanguard Portfolio Management's, at 6.38%. 13 filings are on record since August 8, 2025 (Schedule 13G, May 1, 2026).
Sell to companies like Pacira BioSciences Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Vanguard Capital Management · Sole voting: 297,029 · Shared voting: 0 · Sole dispositive: 1,923,614 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-10-30
- · Reporting person: Doma Perpetual Capital Management LLC · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-10-13
- · Reporting person: State Street Corporation · Sole voting: 0 · Shared voting: 1,944,697 · Sole dispositive: 0 · Shared dispositive: 2,059,977 · SCHEDULE 13G, 2026-08-07
- · Holder: Vanguard Capital Management · Percent: 5.15% · SCHEDULE 13G
- · Holder: Vanguard Portfolio Management · Percent: 6.38% · SCHEDULE 13G
Pacira BioSciences Inc has 13 Schedule 13D or 13G filings on record since 2025-08-08. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Stated intent
Intent stated in Item 4 Doma Perpetual Capital Management LLC
The Reporting Persons sent a letter to the Board of Directors on November 10, 2025 (the "Letter"), which is attached hereto and has been or is being made public.From Item 4 of the SCHEDULE 13D/A filed 2025-11-10
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Vanguard Portfolio Management | 6.38% | 2,585,964 | SCHEDULE 13G, 2026-05-01 | 2026-03-31 |
| State Street Corporation | 5.2% | 2,059,977 | SCHEDULE 13G, 2026-08-07 | 2026-06-30 |
| Dimensional Fund Advisors LP | 5.1% | 2,060,597 | SCHEDULE 13G, 2026-04-09 | 2026-03-31 |
| Renaissance Technologies LLC | 4.98% | 2,138,201 | SCHEDULE 13G/A, 2025-11-13 | 2025-07-01 |
| Vanguard Capital Management | 4.82% | 1,923,614 | SCHEDULE 13G/A, 2026-10-30 | 2026-09-30 |
| Doma Perpetual Capital Management LLC | 0% | 0 | SCHEDULE 13D/A, 2026-10-13 | 2026-10-08 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Pacira BioSciences Inc and the warning signs.
Free to see. No signup.
Keep reading
More on Pacira BioSciences Inc and the records around it.
Pacira BioSciences Inc elsewhere on the record
Companies that share a holder
- Renaissance Technologies LLC also filed stake reports on 46 other companies: AMERICAN PUBLIC EDUCATION INC (Aug 2026), Bolt Biotherapeutics, Inc. (Aug 2026), Commercial Vehicle Group, Inc. (Aug 2026)
- STATE STREET CORPORATION also filed stake reports on 343 other companies: TRADE DESK INC/THE (Oct 2026), CENTRUS ENERGY CORP (Sep 2026), ACADIA PHARMACEUTICALS INC (Aug 2026)
- Dimensional Fund Advisors LP also filed stake reports on 366 other companies: Acadia Healthcare Co Inc (Oct 2026), ADT Inc (Oct 2026), AGCO Corp (Oct 2026)
Watch Pacira BioSciences Inc
Get an email when Pacira BioSciences Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Pacira BioSciences Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pacira BioSciences Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pacira BioSciences Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| State Street Corporation | 0 | 1,944,697 | 0 | 2,059,977 | SCHEDULE 13G, 2026-08-07 |
| Vanguard Capital Management | 297,029 | 0 | 1,923,614 | 0 | SCHEDULE 13G/A, 2026-10-30 |
| Doma Perpetual Capital Management LLC | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
| Doma1 LLC | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
| DOMA Perpetual LO Equity Master Fund LP | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
| DOMA Perpetual Partners GP LLC | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
| Pedro Escudero | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
| The John Templeton Foundation | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
| Doma2 LLC | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-10-13 |
The latest filing identifies Pacira BioSciences Inc by CUSIP 695127100 and gives its principal executive office as 5 Sylvan Way, Suite 300, Parsippany, NJ 07054 (SCHEDULE 13G/A, 2026-10-30).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-08 | Doma Perpetual Capital Management LLC | 5.7% | SCHEDULE 13D |
| 2025-08-13 | Renaissance Technologies LLC | 5.34% | SCHEDULE 13G |
| 2025-11-10 | Doma Perpetual Capital Management LLC intent stated | 6.83% | SCHEDULE 13D/A |
| 2025-11-13 | Renaissance Technologies LLC | 4.98% | SCHEDULE 13G/A |
| 2026-01-02 | Doma Perpetual Capital Management LLC | 6.83% | SCHEDULE 13D/A |
| 2026-03-12 | Doma Perpetual Capital Management LLC | 7.3% | SCHEDULE 13D/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-09 | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-05-01 | Vanguard Capital Management | 5.15% | SCHEDULE 13G |
| 2026-05-01 | Vanguard Portfolio Management | 6.38% | SCHEDULE 13G |
| 2026-08-07 | State Street Corporation | 5.2% | SCHEDULE 13G |
| 2026-10-13 | Doma Perpetual Capital Management LLC | 0% | SCHEDULE 13D/A |
| 2026-10-30 | Vanguard Capital Management | 4.82% | SCHEDULE 13G/A |
Questions about who owns Pacira BioSciences Inc
Who owns Pacira BioSciences Inc?
On this page, 3 holders' latest ownership filings report 5% or more of Pacira BioSciences Inc: Vanguard Portfolio Management (6.38%, Schedule 13G, filed 2026-05-01), State Street Corporation (5.2%, Schedule 13G, filed 2026-08-07) and Dimensional Fund Advisors LP (5.1%, Schedule 13G, filed 2026-04-09).
Who are the largest shareholders of Pacira BioSciences Inc?
By the share each holder's latest filing reports, the largest holders of Pacira BioSciences Inc on this page are Vanguard Portfolio Management (6.38%), State Street Corporation (5.2%) and Dimensional Fund Advisors LP (5.1%).
When did Vanguard Portfolio Management buy into Pacira BioSciences Inc?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Portfolio Management on this page is the Schedule 13G, filed 2026-05-01, reporting 6.38%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 13 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Pacira BioSciences Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.